1. Home
  2. CNA vs VTRS Comparison

CNA vs VTRS Comparison

Compare CNA & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNA Financial Corporation

CNA

CNA Financial Corporation

HOLD

Current Price

$46.56

Market Cap

12.9B

Sector

Finance

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$12.43

Market Cap

14.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNA
VTRS
Founded
1853
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
14.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CNA
VTRS
Price
$46.56
$12.43
Analyst Decision
Hold
Hold
Analyst Count
1
6
Target Price
$53.00
$11.50
AVG Volume (30 Days)
532.2K
8.6M
Earning Date
02-09-2026
02-26-2026
Dividend Yield
8.25%
3.85%
EPS Growth
N/A
N/A
EPS
3.66
N/A
Revenue
$14,850,000,000.00
$14,124,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$21.34
$1.18
P/E Ratio
$12.73
N/A
Revenue Growth
5.41
N/A
52 Week Low
$43.29
$6.85
52 Week High
$51.34
$12.68

Technical Indicators

Market Signals
Indicator
CNA
VTRS
Relative Strength Index (RSI) 45.92 71.76
Support Level $46.24 $12.19
Resistance Level $47.77 $12.68
Average True Range (ATR) 0.62 0.27
MACD -0.15 -0.00
Stochastic Oscillator 14.36 79.28

Price Performance

Historical Comparison
CNA
VTRS

About CNA CNA Financial Corporation

CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance. The company operates under five segments: Specialty, Commercial and International being its core business, and two segments for its non-core businesses, which are Life and Group and Corporate and Other. CNAF, through its segments, provides professional, financial, specialty property, and casualty products to small businesses and medium-scale organizations. It has its business spread across Continental Europe, United Kingdom, and Canada. The majority of the revenues are generated from the Specialty and Commercial segment of the business.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: